Top 20 Medical Startup Investors in Portugal (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Portugal Ventures
VC Fund
|
9 | Portugal, United States, France | Seed, Pre-Seed | Software, Information Technology, Health Care | $110k–$2.1M |
|
Armilar Venture Partners
VC Fund
|
5 | Portugal, United States, United Kingdom | Seed, Series A | Software, Information Technology, Artificial Intelligence | $500k–$16M |
|
Vesalius Biocapital Partners
VC Fund
|
4 | Belgium, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$100M |
|
TheVentureCity
VC Fund
|
3 | United States, Spain, Brazil | Seed, Pre-Seed, Series A | Software, SaaS, Artificial Intelligence | $100k–$45M |
|
Caixa Capital
VC Fund
|
3 | Portugal, United States, Spain | Seed, Series A | Software, Information Technology, SaaS | $120k–$12M |
|
SOSV
VC Fund
|
2 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Critical Ventures
VC Fund
|
2 | Portugal, United States | Seed, Series A | Medical, Computer, Genetics | $1.2M–$13M |
|
Boule Diagnostics
VC Fund
|
1 | Portugal | Series A | Medical, Health Care, Medical Device | |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
1 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.3M–$50M |
|
OrbiMed
VC Fund
|
1 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$150M |
|
Torrey Pines Investment
VC Fund
|
1 | United States, Russian Federation, The Netherlands | Seed, Pre-Seed | Biotechnology, Health Care, Pharmaceutical | $3M–$3.1M |
|
Biovance Capital
VC Fund
|
1 | Portugal, The Netherlands | Seed, Series A | Medical, Biotechnology, Product Research | |
|
Iberis Capital
VC Fund
|
1 | Portugal, Spain, United States | Series A, Seed | Software, Information Technology, SaaS | $2.2M–$43M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
1 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $909k–$33M |
|
Green Innovations
VC Fund
|
1 | Portugal | Series A | Medical, Genetics, Health Care | |
|
Shilling VC
VC Fund
|
1 | Portugal, Spain, United States | Seed, Pre-Seed, Series A | Information Technology, Software, Internet | $208k–$16M |
|
ChangePartners
VC Fund
|
1 | Portugal | Seed | Medical, Therapeutics, Biotechnology | |
|
Social Impact Fund
VC Fund
|
1 | Portugal, United States | Seed | Apps, Video, Medical | $942k–$2.5M |
|
Artesian VC
VC Fund
|
1 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $40k–$15M |
|
Demium Capital
VC Fund
|
1 | Spain, Portugal, Poland | Pre-Seed, Seed, Series A | Software, FinTech, Health Care | $110k–$3.1M |
| Access all 32 investors in Portugal Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Verticals:Enterprise, SaaS, Security, Networks, AI, VR/AR, Marketplace, Blockchain, Internet of Things, New materials, Electronics, Robotics, Cleantech, Agrotech, Seatech, Therapeutics, Digital Health, Diagnostics, Innovative Accommodation, Tourist Entertainment Companies, Tour Operators, Wine, Nautical and Equestrian Tourism, Theme ParksMobile, Robotics Founded in 2012, Portugal Ventures is a venture capital firm based in Porto, Portugal. The firm is a part of the Banco Português de Fomento group. The firm seeks to invest in pre-seed, seed and series A stages
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed
- Geography: Portugal, United States, France
Investor stats
- Total investments: 225
- Round size: Seed $110k–$2.1M; Pre-Seed $110k–$658k
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — last raise in 2011
Portfolio highlights
- PLUTOS — We are here to make sure that your Puppy gets the best treat! PLUTOS were created specifically for dogs to have fun. Find out our dog healthy chews.
- SCUBIC — SCUBIC is a developer of a cloud-based analytics platform. They were designed to help water utilities and industries improve the management of water supply systems. They combine water management, energy efficiency techniques, data science, hydraulics, and software engineering in order to deliver impactful solutions that improve systems andprocesses. They are specialized services that account for the energy usage in homes, service buildings, or industrial plants.
- KeepIt Energy — KeepIt - KeepIt will place an energy storage technology on the market and thus contribute to a successful energy transition. This technology, which can potentially be used in different market segments, from home solar systems in developing countries to grid support in developed countries, will make an important contribution to harmonisingproduction and consumption in a world that runs on electricity produced entirely from renewable sources. KeepIt is a spin-off from the Faculty of Sciences of the University of Lisbon, stemming from the doctoral work in which its founding partners were involved.
Armilar Venture Partners is Portugal's leading venture capitalist. An independent VC with a 20-year-old history, a high-performance track record and an international footprint, Armilar is a deep-tech investor in ICT, HealthTech and CleanTech.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 101
- Round size: Seed $500k–$4.8M; Series A $4M–$16M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $53M in 2019
Portfolio highlights
- Equall — Equall offers legal AI systems to help companies and lawyers evaluate and control risk.
- DOJO AI — Dojo AI is pioneering the Marketing Operating System (MOS) category, providing challenger brands with enterprise-grade marketing infrastructure. Its proprietary technology combines real-time market intelligence, specialized AI agents, and automated workflow orchestration in one unified platform.The Dojo MOS enables marketing teams to run theirentire operation - from market research and strategy to content creation and campaign execution - through a single, intelligent system. The platform features a proprietary graph engine for real-time market intelligence, marketing-specific language models, and autonomous AI agents trained for specialized marketing tasks.Built for challenger brands looking to compete more effectively, Dojo eliminates the need for multiple point solutions and reduces dependency on external agencies. The platform continuously learns and optimizes, providing companies with compounding advantages as they scale their marketing operations.
- DareData —
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Belgium, Germany, France
Investor stats
- Total investments: 59
- Round size: Series A $3.8M–$20M; Series B $4.4M–$27M; Series C $6.9M–$100M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
- ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
TheVentureCity is a global early-stage venture fund, investing in product-centric startups across the US, Europe, and Latam. With more than $150M under management, the firm invests from pre-seed and seed with a ticket size from $100-500k to Series A with $1-4M.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Spain, Brazil
Investor stats
- Total investments: 133
- Round size: Seed $100k–$4.9M; Pre-Seed $100k–$1.2M; Series A $3M–$45M
- Lead/follow: 11% lead, 89% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Count — Explore, refactor, and share your data at warp speed.
- Passport — Passport is the modern shipping carrier for international ecommerce that helps direct-to-consumer brands ship their products internationally.
- Belo — Crypto for everyone, everyday
Caixa Capital is the Private Equity and Venture Capital arm of banking Group Caixa Geral de Depósitos and has a track record spanning over two decades of activity, since the industry was created in Portugal. It is a leading investor in terms of funds under management, portfolio size and diversity.Caixa Capital´s mission is to invest in fundsand companies, led by highly qualified management teams, with high growth and valuation potential, that enable our funds to achieve an attractive risk adjusted return and for society at large to benefit sustainably from our activity.Currently with more than 700 million Euros under management and a portfolio of over 80 investments, Caixa Capital is a reference in this area with special links to the respective European sector associations.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A
- Geography: Portugal, United States, Spain
Investor stats
- Total investments: 67
- Round size: Seed $120k–$2.5M; Series A $3M–$12M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Veniam — Transfer 10x more data for your video telematics, fleet operations, industrial IoT or connected vehicles.
- Noxus — At Spot, we're crafting the operating system for tomorrow's workforce, harnessing AI to streamline influencer marketing. Our platform empowers agencies, businesses, and content creators to collaborate effectively and reach audiences with ease.
- Infraspeak — Infraspeak is an Intelligent CMMS Software that brings outstanding flexibility, connectivity and intelligence to your operations.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
We invest in game-changing companies with the power to transform the way the world uses technology.
Show more...Investment focus
- Industry: Medical, Computer, Genetics
- Stage:Seed, Series A
- Geography: Portugal, United States
Investor stats
- Total investments: 6
- Round size: Seed $1.2M–$13M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- hOS — hOS is an early-stage AI technology company.
- Kirontech — Detect & manage wasteful practices
- RunSafe Security — Secure embedded systems with RunSafe Security's runtime cybersecurity protection, integrating build-time defenses without affecting performance.
Boule develops, manufactures, and markets hematology analyzers for both human and veterinary markets. Read more about us here.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Portugal
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Biosurfit — At biosurfit they are working to shape the future of in-vitro diagnostic testing. They want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 94
- Round size: Seed $1.3M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Perfood — Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects.
- Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
- Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 576
- Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$131M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
- resTORbio — Restore Beauty - Rethink Bio
- Caris Life Sciences — Caris fulfills the promise of precision oncology through advanced laboratory testing, including tumor profiling and blood-based cancer diagnostics.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Torrey Pines Investment, founded in 2002, is a specialty life-science investment company located in San Diego.Torrey Pines has a team of investment professionals with extensive experience in entrepreneurship, venture capital and operations. Our firm has created biopharma incubators investing in early development stage assets from internationalpharma and biotech partners in CNS, oncology, and virology areas to bring them to commercial success through pharma partnering and M&A.We are committed to capitalizing on the unique opportunities in biotech and pharma, where we can add value in development or regulatory strategy by utilizing resources of our portfolio CRO companies. We seek to leverage our industry knowledge, network of industry and financial contacts, and internal resources to assist our portfolio management in developing and executing their business strategy. Our bottom line is to help our companies achieve growth, build value and realize wealth.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: United States, Russian Federation, The Netherlands
Investor stats
- Total investments: 32
- Round size: Seed $3M–$3.1M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $60M in 2017
Portfolio highlights
- Mondego Bio — Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile.
- BIMINI Biotech — BIMINI Biotech is a startup that develops innovative therapeutic strategies for oncology. It is developing therapeutic strategies that target the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases, and aging.The company was founded in 2019 and is based in Leiden, TheNetherlands.
- MAIR PHARMACEUTICALS — Mair Pharmaceutical creates innovative processes and produces well-known unique substances for pharmaceutical and biopharmaceutical firms worldwide.
Biovance Capital is a new € 51M fund to invest in early-stage biotech companies across Europe developing innovative therapeutics in all disease areas and drug modalities (small and large molecules, vaccines, cell, and gene therapies).
Show more...Investment focus
- Industry: Medical, Biotechnology, Product Research
- Stage:Seed, Series A
- Geography: Portugal, The Netherlands
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Laigo Bio — Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders.
- Mondego Bio — Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile.
Iberis is an investment manager that operates a value-oriented investment management.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Series A, Seed
- Geography: Portugal, Spain, United States
Investor stats
- Total investments: 29
- Round size: Seed $2.2M–$3.2M; Series A $6M–$43M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- LOQR — Increase your business and reduce costs with the best AI-Powered Journey-as-a-Service provider for financial institutions.
- Connected — Connected is a startup that offers affordable connecting humans, unleashing a new wave of IoT-based business models and contributing to bridge the digital gap.
- Sound Particles — A CGI-like software for Sound Design, capable of using particle systems to generate thousands of sounds in a virtual 3D world
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 542
- Round size: Seed $909k–$6.5M; Series A $3M–$33M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- Sdui — Sdui is the solution for mobile communication in schools. With amazingly easy features for messaging, timetables and a wide range of third party integrations, the app digitizes processes and reduces administrative effort. Within two years, Sdui has reached hundreds of institutions and grown a serious reputation in the educational market.
- envelio — We are driving forward the energy transition with our smart grid solutions for grid operators. Get information now and plan smart!
- Atriva Therapeutics — Therapies against viral infections. First-in-class host-targeting therapies to treat respiratory viral infections, including COVID-19 and influenza.
International, Life Sciences, Biotechnology
Show more...Investment focus
- Industry: Medical, Genetics, Health Care
- Stage:Series A
- Geography: Portugal
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CBR Genomics — We apply our end-to-end solutions to hand genetic reports at the clinical desk. We make Genomics accessible!
Shilling is an early-stage venture capital firm backing exceptional founders from the start.Shilling invests in a wide range of verticals and seeks out the biggest opportunities across all B2B and consumer categories. Leveraging the concept of Founder LPs, Shilling brings much more than capital and offers through its Shilling Platform, directaccess to successful founders and executives of leading companies. This platform supports entrepreneurs in validating and developing their ventures, which then accelerate their growth into global markets.
Show more...Investment focus
- Industry: Information Technology, Software, Internet
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, Spain, United States
Investor stats
- Total investments: 79
- Round size: Seed $603k–$5M; Pre-Seed $208k–$3M; Series A $2.4M–$16M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Algori — Improving FMCG growth with the fastest and most granular insights from 45,000 shoppers in Spain
- Manie —
- Musiversal — Record your music in real time with world-class session musicians, vocalists, producers and audio engineers
ChangePartners is an independent company dedicated to mid-size transactions in the Iberian market. They develop high value added solutions specific to each particular situation , offering a fair and unbiased opinion. Their independence guarantees no conflicts of interest. Their small size and focus ensures full dedication to each transaction.
Show more...Investment focus
- Industry: Medical, Therapeutics, Biotechnology
- Stage:Seed
- Geography: Portugal
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Exogenus Therapeutics — Exogenus Therapeutics is engineering cell biology for innovative therapeutic solutions.Exo-T is a biotechnology company dedicated to the pre-clinical and clinical development of innovative cellular-based therapies applied to regenerative medicine, specifically for the skin lesions treatment. The company is presently developing its first product,Exo-Wound, for the treatment of chronic wounds.The project that led to the creation of the company (Nanoinspire) participated in COHiTEC 2014 program and is the result of the research developed in collaboration with Crioestaminal SA, Biocant, and Centre for Neurosciences and Cellular Biology of Coimbra University.
SIF provides financial support for public charities & acts as a fiscal agent for charities and foundations.
Show more...Investment focus
- Industry: Apps, Video, Medical
- Stage:Seed
- Geography: Portugal, United States
Investor stats
- Total investments: 3
- Round size: Seed $942k–$2.5M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Criam — CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused in the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as aplatform approach we will be able to monitor, control and contain diseases worldwide.
- MemoryWell — MemoryWell is a digital platform for storytelling that brings the skills of professional writers to the challenge of helping elders tell their life story. With MemoryWell+, you can build a collaborative timeline around that story, adding photos, videos, letters and documents. Everyone has a story, let us help you capture it.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 223
- Round size: Seed $120k–$4M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
- Living Models — Living Models is concentrating on this field by employing AI methods on biological data, especially in plant science, where enhancing crop yield and resilience is becoming crucial as global agriculture is impacted by climatic challenges.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more...Investment focus
- Industry: Software, FinTech, Health Care
- Stage:Pre-Seed, Seed, Series A
- Geography: Spain, Portugal, Poland
Investor stats
- Total investments: 81
- Round size: Seed $110k–$3.1M; Pre-Seed $110k–$329k
- Lead/follow: 62% lead, 38% follow
- Last fund: May invest from a new fund soon — raised $52M in 2020
Portfolio highlights
- Qalea —
- Dealcar — DEALCAR is a company that digitalizes the used car market through a SaaS platform, enabling fully digital transactions. This platform creates a network effect benefiting dealers, partners, and customers. • Dealers: Increase revenue by selling extra products and boost sales by reducing turnover time. • Partners: Distribute products at the pointof sale without marketing expenses, lowering operational costs. • Consumers: Purchase a used car easily in just three steps, enjoying a smooth, trusted process similar to renting but with the benefits of owning a car.
- KomboAI — Supercharge your CRM and close more deals with KomboAI Find the right leads, engage them with purpose and improve your skills every day. Book a Demo See Kombo in Action Over 1000+ sales reps are already using KomboAI during their job Join the sales revolution today Find the right leads Receive every day new leads
Medical Investor funding in Portugal at a glance
Stats across 29 deals from 32 investors.
Access all 32 investors in Portugal Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Portugal investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 32 investors investing in Portugal Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!